Delirium Clinical Trial
Official title:
The Impact of Intravenous Administration of Perioperative Acetaminophen and Ibuprofen Combination (Maxigesic®) on Postoperative Delirium in Elderly Patients Undergoing Minimally Invasive Lung Segmentectomy or Lobectomy
The primary aim of this interventional study is to investigate the impact of perioperative administration of Maxigesic (combination of acetaminophen and ibuprofen) on delirium after minimally invasive lung surgery in elderly patients. The Maxigesic group receives a total of 5 doses of Maxigesic (20mg/kg, maximum dose per serving: 1g) every 6 h from immediately after anesthesia induction. The control group receives the same volume of normal saline. Researchers compare the incidence and severity of postoperative delirium for 5 days after surgery.
Status | Recruiting |
Enrollment | 176 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - Patients aged 65 years or older undergoing minimally invasive lung lobectomy or segmentectomy Exclusion Criteria: - Hypersensitivity to the main ingredients and additives of Maxigesic - Hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) - Alcoholism / Alcohol intoxication - Severe hematological abnormalities - Bleeding tendency (e.g., Spontaneous bleeding) - Severe hepatic dysfunction (AST, AST =2.5 * upper normal limit(UNL) or Total bilirubin =3.0 mg/dl) - Severe renal dysfunction (eGFR <30 ml/min/1.73m2 or Dialysis) - Severe heart failure (Left ventricle ejection fraction <30%) - Uncontrolled hypertension(HTN) (Systolic blood pressure >180 mmHg) - Symptomatic asthma in need of treatment - Anticoagulants or antiplatelet agents are maintained for up to 5 days before surgery - Barbiturates or tricyclic antidepressants (TCAs) - High-dose methotrexate (MTX) for cancer treatment - Preoperative cognitive impairment, dementia, or delirium - Inability to understand the research and instructions for this study |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Korea University Guro Hospital | Seoul |
Lead Sponsor | Collaborator |
---|---|
Korea University Guro Hospital | Kyongbo Pharmaceutical Co.,Ltd |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of postoperative delirium(POD) | Confusion assessment method(CAM)/Confusion Assessment Method for the ICU (CAM-ICU) or delirium record on electrical medical record(EMR) will be used for the evaluation of POD. | From immediately after surgery to 5 days after surgery | |
Secondary | Severity of POD | CAM-S(severity) will be utilized to assess the severity of POD. (*CAM-S is measured on 0-7 (short form) and 0-19 (long form) scale, and the higher the score, the greater the POD severity.) | From immediately after surgery to 5 days after surgery | |
Secondary | Duration of POD | CAM/CAM-ICU or delirium record on EMR will be used to estimate the duration of POD. | From immediately after surgery to 5 days after surgery | |
Secondary | Preoperative cognition | Mini-mental state examination(MMSE) will be used to evaluate the participants' preoperative cognition. (*MMSE is measured on 0-30 scale, and the lower the score, the more cognitively impaired the patient is.) | 1 day before surgery | |
Secondary | Preoperative cognition | Montreal cognitive assessment(MoCA) will be used to evaluate the participants' preoperative cognition. (*MoCA is measured on 0-30 scale, and the lower the score, the more cognitively impaired the patient is.) | 1 day before surgery | |
Secondary | Preoperative frailty | Clinical frailty scale(CFS) will be utilized to assess the preoperative frailty (*CFS is used to determine comprehensive geriatric assessment. It is measured on 1-9 scale, and the higher the scale, the more frail the patient is.) | 1 day before surgery | |
Secondary | Postoperative pain | Numerical rating scale (NRS) or Visual analogue scale (VAS) will be used to determine the postoperative pain severity (*NRS and VAS are measured on a 0-10 scale, and the higher the score, the more severe the patient's pain. If the patient can verbalize their pain, use the NRS; otherwise, use the VAS to assess pain). | Immediately after surgery to postoperative 48 hours | |
Secondary | Consumption of opioids | Opioid consumption is measured by converting them into morphine equivalents. | Immediately after surgery to postoperative 48 hours | |
Secondary | Postoperative nausea, vomiting | Nausea is measured by scoring on a scale of 0-10. The higher the score, the more severe the symptom. Whether the patients vomit or not is observed and recorded. | Immediately after surgery to postoperative 48 hours | |
Secondary | ICU stay | Determine how many days the participant stays in the ICU. | Immediately after surgery to ICU discharge(usually within about 5 days after surgery) | |
Secondary | Hospital stay | Determine how many days the participant stays in the hospital. | Immediately after surgery to hospital discharge(usually within about 30 days after surgery) | |
Secondary | Postoperative complications | Investigate all kinds of complications that occur after surgery. | Immediately after surgery to hospital discharge(usually within about 30 days after surgery) | |
Secondary | Drug side effects | Investigate complications suspected to be side effects caused by the study drug. | Immediately after surgery to hospital discharge(usually within about 30 days after surgery) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04551508 -
Delirium Screening 3 Methods Study
|
||
Recruiting |
NCT05891873 -
Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
|
||
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Recruiting |
NCT06194474 -
Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
|
||
Completed |
NCT03095417 -
Improving the Recovery and Outcome Every Day After the ICU
|
N/A | |
Completed |
NCT05395559 -
Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
|
||
Terminated |
NCT03337282 -
Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
|
||
Not yet recruiting |
NCT04846023 -
Pediatric Delirium Screening in the PICU Via EEG
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Withdrawn |
NCT02673450 -
PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
|
||
Recruiting |
NCT03256500 -
Transcranial Direct Current Stimulation for the Treatment of Delirium
|
N/A | |
Completed |
NCT02890927 -
Geriatric-CO-mAnagement for Cardiology Patients in the Hospital
|
N/A | |
Not yet recruiting |
NCT02892968 -
ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients
|
N/A | |
Recruiting |
NCT03165539 -
Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
|
||
Completed |
NCT02554253 -
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
|
Phase 2 | |
Completed |
NCT02518646 -
DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models
|
N/A | |
Recruiting |
NCT02305589 -
The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium
|
N/A | |
Completed |
NCT02628925 -
Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale
|
N/A |